Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

BD intent to separate business could allow competitors to rise in IVD test markets, says GlobalData

Becton Dickinson (BD) has recently announced its intent to separate its biosciences and diagnostic solutions business. The biosciences segment includes research instruments and reagents, and single-cell multiomics, while the diagnostic solutions segment consists of microbiology and infectious disease diagnostics. According to the company, the two segments earned over $3 billion in revenue in fiscal 2024. BD’s […]
Read more

Trump’s proposed tariffs to impact US pharma FDI in Canada, Mexico, China and Europe, reveals GlobalData

The pharmaceutical industry is preparing for major disruptions following Trump’s tariff announcement—25% on imports from Canada and Mexico (both paused for 30 days) and 10% on China. These tariffs could worsen drug shortages, raise prices, and push manufacturers to reconsider their market strategies. Additionally, the proposed tariffs are expected to impact pharmaceutical foreign direct investment […]
Read more

India robotic surgical systems market to record 10% CAGR during 2024-36, driven by increasing adoption, says GlobalData

The installation of a surgical robot at the All India Institute of Medical Sciences (AIIMS) in Delhi recently marks a testament to the Indian government’s commitment to narrowing the disparity between public and private healthcare services in terms of quality and technological advancements. In light of this context, the market for robotic surgical systems in […]
Read more

AI-driven virtual care innovations will continue to gain traction to navigate workforce challenges, says GlobalData

With healthcare facilities facing staff shortages and increased patient loads, innovative AI-driven solutions are becoming a necessity. Solutions from companies like Vitalacy, Current Health, and Care.ai, are leveraging artificial intelligence (AI), sensor technology, and real-time monitoring to enhance patient safety and optimize hospital efficiency. As such, AI-driven healthcare innovations will continue to gain traction, helping […]
Read more

Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData

The Duchenne muscular dystrophy (DMD) market across the seven major markets (7MM*) is set to grow from $2.3 billion in 2023 to $5.2 billion in 2033, driven by the recent approvals of innovative therapies such as Sarepta Therapeutics and Roche’s Elevidys (delandistrogene moxeparvovec), and Santhera Pharmaceuticals’ Agamree (vamorolone), according to GlobalData, a leading data and […]
Read more

India transcatheter aortic valve replacement market to record 24% CAGR during 2024-33, forecasts GlobalData

Heart valve diseases, particularly rheumatic heart disease and degenerative aortic stenosis, remain a major burden in India. It is worsened by socioeconomic challenges and limited healthcare access. Against this backdrop, India’s transcatheter aortic valve replacement (TAVR) market is forecast to register a compound annual growth rate (CAGR) of around 24% between 2024 and 2033, according […]
Read more

Chanel’s advertising focuses on artistry, empowerment, and cultural engagement to connect with consumers, reveals GlobalData

Chanel’s advertising endeavors between November 2024 and January 2025 highlight its strategic focus on captivating audiences through a blend of artistic storytelling and high-profile collaborations. These initiatives aim to solidify Chanel’s status as a purveyor of luxury and a champion of creative expression. By emphasizing the values of sophistication, empowerment, and cultural appreciation, Chanel seeks […]
Read more
1 … 47 48 49 50 51 … 136